Pendal Group LTD Abiomed Inc Transaction History

Pendal Group LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 01, 2019	SELL	$250.96 - $284.94 $1.98 Million - $2.24 Million	-7,875 Closed	0 $0
Q1 2019 May 01, 2019	SELL	$276.39 - $362.25 $1.99 Million - $2.61 Million	-7,207 Reduced 47.79%	7,875 $0
Q4 2018 Jan 30, 2019	SELL	$281.08 - $444.25 $7.44 Million - $11.8 Million	-26,475 Reduced 63.71%	15,082 $4.9 Million
Q3 2018 Nov 05, 2018	BUY	$354.53 - $449.75 $7.12 Million - $9.03 Million	20,087 Added 93.56%	41,557 $0
Q2 2018 Jul 18, 2018	BUY	$278.07 - $446.21 $5.97 Million - $9.58 Million	21,470 New	21,470 $0

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Pendal Group LTD, based on Form 13F filings with the SEC.

Stay updated on Pendal Group LTD with notifications on news.